Peer-influenced content. Sources you trust. No registration required. This is HCN.
Healthline
Studies show that bipolar disorder patients with severe symptoms demonstrate significant impairment in prospective memory – the ability to remember and execute planned future actions.
Psychiatry December 4th 2024
Psych Congress Network
Lithium continues to be recognized as the most reliable mood stabilizer for bipolar disorder patients with a history of mania, necessitating precise management of dosages to prevent significant side effects.
Psychiatry May 7th 2024
Epoch Health
This recent Supreme Court ruling sheds light on the critical intersection of mental health and legal standards, offering an essential perspective for healthcare professionals involved in forensic or psychiatric fields.
Psychiatry April 9th 2024
Psychiatrist.com
Recent advancements in the treatment of acute agitation offer promising non-invasive options, such as inhaled loxapine and sublingual dexmedetomidine, aligning with the shift towards patient-centered care and minimizing the use of coercive measures.
Psychiatry February 13th 2024
Lamotrigine stands out for its efficacy in preventing depressive episodes in bipolar I disorder, offering a nuanced option for mood stabilization with an antidepressant emphasis. Understanding its specific clinical applications can enhance treatment strategies for mood disorders.
Clinical Pharmacology February 13th 2024
In a phase 3 study, iloperidone demonstrated a significant improvement in treating bipolar mania, marked by a reduction in the Young Mania Rating Scale (YMRS) scores.
Psychiatry February 6th 2024